99 related articles for article (PubMed ID: 11793449)
1. Genome-wide search for loss of heterozygosity in Burkitt lymphoma cell lines.
Sobol H; Benziane A; Kerangueven F; Yin L; Noguchi T; Pauly S; Eisinger F; Longy M; Romeo G; Lenoir G; Birnbaum D
Genes Chromosomes Cancer; 2002 Feb; 33(2):217-24. PubMed ID: 11793449
[TBL] [Abstract][Full Text] [Related]
2. High frequency of EBV association with non-random abnormalities of the chromosome region 1q21-25 in AIDS-related Burkitt's lymphoma-derived cell lines.
Polito P; Cilia AM; Gloghini A; Cozzi M; Perin T; De Paoli P; Gaidano G; Carbone A
Int J Cancer; 1995 May; 61(3):370-4. PubMed ID: 7729949
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
[TBL] [Abstract][Full Text] [Related]
4. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
Maria Murga Penas E; Schilling G; Behrmann P; Klokow M; Vettorazzi E; Bokemeyer C; Dierlamm J
Genes Chromosomes Cancer; 2014 Jun; 53(6):497-515. PubMed ID: 24590883
[TBL] [Abstract][Full Text] [Related]
6. Genetic differences between paediatric and adult Burkitt lymphomas.
Havelange V; Pepermans X; Ameye G; Théate I; Callet-Bauchu E; Barin C; Penther D; Lippert E; Michaux L; Mugneret F; Dastugue N; Raphaël M; Vikkula M; Poirel HA
Br J Haematol; 2016 Apr; 173(1):137-44. PubMed ID: 26887776
[TBL] [Abstract][Full Text] [Related]
7. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
8. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
[TBL] [Abstract][Full Text] [Related]
9. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
10. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
[TBL] [Abstract][Full Text] [Related]
11. A search for novel tumour suppressor genes for adult acute leukaemia by allelotyping at sub-telomeric chromosomal regions.
Giphart-Gassler M; De Nooij-Van Dalen A; Van Buuren-Van Seggelen V; Morolli B; Lohman P; Kluin-Nelemans H
Mutat Res; 1998 May; 400(1-2):409-19. PubMed ID: 9685700
[TBL] [Abstract][Full Text] [Related]
12. TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma.
Teitell MA; Lones MA; Perkins SL; Sanger WG; Cairo MS; Said JW
Am J Clin Pathol; 2005 Oct; 124(4):569-75. PubMed ID: 16146820
[TBL] [Abstract][Full Text] [Related]
13. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines.
Parsa NZ; Gaidano G; Mukherjee AB; Hauptschein RS; Lenoir G; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1994 Jan; 9(1):13-8. PubMed ID: 7507695
[TBL] [Abstract][Full Text] [Related]
15. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
Boerma EG; Siebert R; Kluin PM; Baudis M
Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
[TBL] [Abstract][Full Text] [Related]
16. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
Okano M; Aya T; Mizuno F; Takada K; Osato T
Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
[TBL] [Abstract][Full Text] [Related]
17. EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain.
Maeda A; Kiss C; Chen F; Ehlin-Henriksson B; Nagy N; Szekely L; Takada K; Klein E; Klein G
Int J Cancer; 2001 Sep; 93(5):714-9. PubMed ID: 11477584
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
Zhang T; Ma J; Nie K; Yan J; Liu Y; Bacchi CE; Queiroga EM; Gualco G; Sample JT; Orazi A; Knowles DM; Tam W
Blood Cancer J; 2014 Nov; 4(11):e261. PubMed ID: 25382611
[TBL] [Abstract][Full Text] [Related]
19. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
[TBL] [Abstract][Full Text] [Related]
20. No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patients.
Bornkamm GW; von Knebel-Doeberitz M; Lenoir GM
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4930-4. PubMed ID: 6087353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]